Testosterone use in midlife women - an endocrine perspective

Testosterone is currently licensed for use in hypoactive sexual desire disorder (HSDD) in addition to menopause hormonal therapy (MHT). Other additional benefits lack robust evidence to date.

Maritza will review the endocrinology of testosterone in women, summarise the current evidence and how best to counsel and treat women in primary care.